<div id="readability-page-1"><div>         <div>                        <p><b>In this free webinar, see how competitive intelligence should actually work for pharma decision-making. Attendees will learn why the &#34;every team builds their own CI&#34; model creates contradictory intelligence, and what it actually costs in delayed decisions and duplicated spend. The featured speaker will discuss the difference between competitive monitoring (collecting signals) and decision infrastructure (routing the right intelligence to the right team at the right time). Attendees will gain insight into what a three-layer CI architecture looks like with global data scale, proprietary primary intelligence and custom per-function decision workflows on one shared foundation. The speaker will share how leading pharma companies are turning CI from a support function into an enterprise infrastructure that serves every team from one source of truth. </b></p><p>,  /PRNewswire/ -- Competitive intelligence (CI) in pharma has a paradox at its center: every function needs it, but when each team builds its own approach, the result is fragmentation, duplicated effort and conflicting decisions. This webinar explores why that model persists, how it weakens decision-making across the organization and why a more unified approach to CI is needed.</p>             <p><span>                 Continue Reading                   <br/>                   <i></i>                                </span>             </p>             <div>               <div>                 <div>                                       <div>                                                               <figure>                        <p><img id="imageid_2" src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/>                    </p>                       <figcaption>         www.anervea.ai       </figcaption>     </figure>                                                                                  </div>                 </div>               </div>             </div>             <p>When intelligence is scattered across teams and reduced to dashboards and alerts, the function can lose strategic influence. Instead of shaping business decisions, it is often treated as a support service. This session examines the limits of competitive monitoring alone and introduces a broader framework in which one shared intelligence foundation supports multiple functions through tailored views, workflows and decision routing.</p>                            <p>The featured speaker will unpack why the current model of fragmented CI persists, what it actually costs organizations in delayed decisions and duplicated effort, and what a fundamentally different architecture looks like, one where public data at a global scale, proprietary primary intelligence from the field and custom per-function decision workflows converge into a single source of truth.</p>               <p>Register for this webinar to learn how competitive intelligence should actually work for pharma decision-making.</p><p>Join experts from Anervea.AI, Dr. Sanika Bhide, Vice President, Enterprise Partnerships; and Stephen Shewbrooks, Vice President, US Sales, for the live webinar on Tuesday, June 2, 2026, at 1pm EDT (7pm CEST/EU-Central).</p><p>For more information, or to register for this event, visit Beyond Monitoring: How AI Is Turning Pharma CI into a Commercial Decision Engine.</p><p><b>ABOUT XTALKS</b></p><p>Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.</p><p>Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.</p><p>To learn more about Xtalks, visit www.xtalks.com<br/>For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/</p><p>Contact:<br/>Vera Kovacevic<br/>Tel: +1 (416) 977-6555 x371<br/>Email: <span>[email protected]</span></p><p>SOURCE Xtalks</p><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9Tlk1ODg0NiZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNDQ1UFJfTkVXU19VU1BSX19fX19OWTU4ODQ2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9Tlk1ODg0NiZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNDQ1UFJfTkVXU19VU1BSX19fX19OWTU4ODQ2"/></p></div>       </div></div>

<p>A free webinar titled "Beyond Monitoring: How AI Is Turning Pharma CI into a Commercial Decision Engine" will be held on June 2, 2026. It will address the challenges of competitive intelligence (CI) in the pharmaceutical industry, emphasizing the need for a unified approach to avoid fragmentation and conflicting decisions. The session will explore the limitations of current CI practices and introduce a three-layer CI architecture that integrates global data, proprietary intelligence, and tailored workflows. Experts from Anervea.AI will lead the discussion, aiming to reshape how CI supports decision-making in pharma.</p>

prnewswire

Proshares Ultra Nasdaq Biotech

Health Care Select Sector SPDR

VG Health

ChinaAMC CSI Biotechnology Theme ETF

E Fund Hang Seng SCHK Innovative Drug ETF

VanEck Biotech ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

iShares US Pharma

iShares Biotechnology ETF

E Fund CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Bosera Hang Seng Health Care ETF(QDII)

SPDR S&P Biotech

E Fund CSI 300 Health Care ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Guotai CSI Bio-medicine ETF

iShares Global Healthcare

ChinaAMC SSE STAR Biology and Medicine ETF

Proshares UltraShort Nasdaq Biotech

China Merchants CSI Biotechnology Theme ETF

Direxion S&P Biotech Bull 3X

Minsheng Royal CSI Biotechnology Theme ETF

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

14:45 ETBeyond Monitoring: How AI Is Turning Pharma CI into a Commercial Decision Engine, Upcoming Webinar Hosted by Xtalks